Matches in Nanopublications for { ?s ?p "[The measurement of LPL activity and mass allows identification of the heterozygote state for LPL deficiency, which is characterized by variable expressions of hyperlipidemia and reduced HDL cholesterol.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP475874.RAVh2XFC8FkYADpLhNQ3OSnZuahjYpkwx2hynwyRPn-To130_assertion description "[The measurement of LPL activity and mass allows identification of the heterozygote state for LPL deficiency, which is characterized by variable expressions of hyperlipidemia and reduced HDL cholesterol.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475874.RAVh2XFC8FkYADpLhNQ3OSnZuahjYpkwx2hynwyRPn-To130_provenance.
- assertion description "[The measurement of LPL activity and mass allows identification of the heterozygote state for LPL deficiency, which is characterized by variable expressions of hyperlipidemia and reduced HDL cholesterol.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The measurement of LPL activity and mass allows identification of the heterozygote state for LPL deficiency, which is characterized by variable expressions of hyperlipidemia and reduced HDL cholesterol.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1296316.RAJvNRJFHFVquDpEG11RhWmPVuvEr-_bC4ZHF6dzhwLTw130_assertion description "[The measurement of LPL activity and mass allows identification of the heterozygote state for LPL deficiency, which is characterized by variable expressions of hyperlipidemia and reduced HDL cholesterol.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1296316.RAJvNRJFHFVquDpEG11RhWmPVuvEr-_bC4ZHF6dzhwLTw130_provenance.
- NP1296315.RA6INXRvh2c1yRzAofsU8zcIorkYS1beU641K6nd6u_9k130_assertion description "[The measurement of LPL activity and mass allows identification of the heterozygote state for LPL deficiency, which is characterized by variable expressions of hyperlipidemia and reduced HDL cholesterol.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1296315.RA6INXRvh2c1yRzAofsU8zcIorkYS1beU641K6nd6u_9k130_provenance.